Oxford Nanopore TechnologiesOXFYY -11.92%50 Gross Margin % is 59.09% as of Dec. 2025, which is 9% above its 10-year median of 54.05. GuruFocus rates OXFYY with a GF Score™ of 50/100 and a GF Value™ of $9.79 (Significantly Undervalued). The stock has 2 warning signs investors should review. Among 737 Biotechnology companies, Oxford Nanopore Technologies ranks worse than 51.97% on this metric.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Oxford Nanopore Technologies had a gross margin of 59.09% for the quarter that ended in Dec. 2025 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Oxford Nanopore Technologies Gross Margin % Related Terms
Oxford Nanopore Technologies Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OXFYY vs VRTX, REGN, ALNY: Gross Margin % Comparison
For the Biotechnology subindustry, Oxford Nanopore Technologies's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Oxford Nanopore Technologies Gross Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Oxford Nanopore Technologies's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Oxford Nanopore Technologies's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Oxford Nanopore Technologies (OXFYY) has a Gross Margin % of 59.09% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Oxford Nanopore Technologies and its competitors. This is near median its historical median of 54.05. Over the past decade, Oxford Nanopore Technologies' Gross Margin % has ranged from 41.17 to 62.34. According to the industry distribution chart, Oxford Nanopore Technologies ranks #383 out of 737 companies in the Biotechnology industry, placing it in the top 52%.
Is Oxford Nanopore Technologies' Gross Margin % too high?
Oxford Nanopore Technologies' current Gross Margin % of 59.09% is near median its 10-year median of 54.05. Over the past 10 years, this metric has ranged from a low of 41.17 to a high of 62.34. The Biotechnology industry median Gross Margin % is 60.92. Oxford Nanopore Technologies' value of 59.09% is 3% below this industry median. Based on the distribution chart, Oxford Nanopore Technologies ranks #383 out of 737 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Oxford Nanopore Technologies has a GF Score™ of 50/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Oxford Nanopore Technologies' Gross Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Oxford Nanopore Technologies ranks #383 out of 737 companies for Gross Margin %. This places Oxford Nanopore Technologies in the lower half of its industry. The industry median Gross Margin % is 60.92. Oxford Nanopore Technologies' value of 59.09% is 3% below this benchmark. Historically, Oxford Nanopore Technologies' own Gross Margin % has ranged from 41.17 to 62.34 over the past decade. While the company's 10-year median is 54.05 vs. the industry median of 60.92, Oxford Nanopore Technologies has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Biotechnology company?
The median Gross Margin % among Biotechnology companies is 60.92, based on 737 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Oxford Nanopore Technologies's current Gross Margin % of 59.09% is 3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Oxford Nanopore Technologies and its competitors. For the Biotechnology industry, the median Gross Margin % is 60.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Oxford Nanopore Technologies's current Gross Margin % is 59.09%, which is near median its own 10-year median of 54.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oxford Nanopore Technologies stock overvalued right now?
Based on GuruFocus' analysis, Oxford Nanopore Technologies (OXFYY) is currently considered Significantly Undervalued. The stock's GF Value™ is $9.79, compared to a current price of $6.50 — trading 33.6% below its estimated fair value. The current Gross Margin % is 59.09%, which is near median its 10-year median of 54.05 and 3% below the Biotechnology industry median of 60.92. Oxford Nanopore Technologies' overall GF Score™ is 50/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Oxford Nanopore Technologies (OXFYY), the current Gross Margin % is 59.09% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Oxford Nanopore Technologies (OXFYY) Overvalued in 2026?
Based on GuruFocus' analysis, Oxford Nanopore Technologies stock appears to be undervalued.
The current stock price of $6.50 is trading 33.6% below its estimated GF Value™ of $9.79.
GuruFocus considers Oxford Nanopore Technologies to be Significantly Undervalued.
Key valuation signals for OXFYY:
Gross Margin %: 59.09% (near median its 10-year median of 54.05)
GF Value™: $9.79 vs. price of $6.50 (33.6% below fair value)
Industry Position: 3% below the Biotechnology median (#383 of 737)
No single metric tells the full story. See the OXFYY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Oxford Nanopore Technologies PLC is involved in researching, developing, manufacturing and commercializing deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that provides rich data, is fast, accessible and easy to use, and which allows the real-time analysis of DNA or RNA. It has developed and brought to market a new generation molecular sensing platform based on nanopores. The first application is DNA/RNA sequencing and the platform is also being developed for the analysis of proteins and metabolites. It operates in single segment of providing products and services related to the sale and use of its nanopore-based sensing technology. Geographically its operations are spread across EMES, AMR, and APAC.
50GF Score
Get the complete analysis for OXFYY
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OXFYY has been successfully added to your 
